143516-75-0

Upstream product

• 86520-63-0 2,3,4,6-tetra-O-acetyl-α-galactopyranosyl trichloroacetimidate 
• 143516-79-4 (E)-(R)-2-Benzyloxy-pent-3-en-1-ol 
• 100-39-0 benzyl bromide 
• 143516-74-9 ((E)-(R)-1-Methoxymethoxymethyl-but-2-enyloxymethyl)-benzene 
• 143516-73-8 (2S,3S)-2-Methoxymethoxymethyl-3-vinyl-oxirane 

Downstream Products

• 143516-76-1 (5aR,6S,7aR,13aS,13bS)-6-((E)-(R)-2-Benzyloxy-pent-3-enyloxy)-2,2,4,4,10,10,12,12-octaisopropyl-hexahydro-1,3,5,7,9,11,13-heptaoxa-2,4,10,12-tetrasila-cyclohepta[3,4]benzo[1,2]cyclooctene 
• 143516-80-7 (R)-2-Benzyloxy-3-((5aR,6S,7aR,13aS,13bS)-2,2,4,4,10,10,12,12-octaisopropyl-hexahydro-1,3,5,7,9,11,13-heptaoxa-2,4,10,12-tetrasila-cyclohepta[3,4]benzo[1,2]cycloocten-6-yloxy)-propan-1-ol 

Relevant academic research and scientific papers

Syntheses of a glycerophospholipid, C16-platelet activating factor and a palmitoyl analogue of M-5, an anti-inflammatory glyceroglycolipid

From a chiral C4-epoxide (-)-3, which is one of the synthons in our synthetic strategy for complex lipids, a glycerophospholipid C16-platelet activating factor (C16-PAF, 1) and a palmitoyl analogue (2) of an anti-inflammatory glyceroglycolipid M-5, which was previously isolated from the Okinawan marine sponge Phyllospongia foliascens, have been synthesized.